Treatment of patients experiencing severe BEs in PERSEPT 1 and PERSEPT 2 with eptacog beta. Time points for the first recorded “good” or excellent” hemostasis evaluation obtained from the treating physician and from the patient/caregiver for each BE are noted by asterisks. Treatment outcomes of “bleed control” or “insufficient response” are indicated.